InvestorsHub Logo

DewDiligence

05/13/07 5:02 AM

#1569 RE: genisi #1568

>Mylan beats Teva for Merck KGaA<

Sometimes you win by losing, and this is one of those cases, IMHO. In other words, I think TEVA showed discretion and MYL is paying too much.